These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1697 related articles for article (PubMed ID: 26767992)
1. Medical use of cannabis products: Lessons to be learned from Israel and Canada. Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992 [TBL] [Abstract][Full Text] [Related]
2. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. Krcevski-Skvarc N; Wells C; Häuser W Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Rice J; Cameron M Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025 [TBL] [Abstract][Full Text] [Related]
4. Medical marijuana for cancer. Kramer JL CA Cancer J Clin; 2015 Mar; 65(2):109-22. PubMed ID: 25503438 [TBL] [Abstract][Full Text] [Related]
5. Medical cannabis: considerations for the anesthesiologist and pain physician. Beaulieu P; Boulanger A; Desroches J; Clark AJ Can J Anaesth; 2016 May; 63(5):608-24. PubMed ID: 26850063 [TBL] [Abstract][Full Text] [Related]
6. Cannabis and cannabinoids. Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748 [No Abstract] [Full Text] [Related]
7. [Cannabis as a therapeutic agent: Focal topic]. Radbruch L; Schäfer M Schmerz; 2016 Feb; 30(1):1-2. PubMed ID: 26809973 [No Abstract] [Full Text] [Related]
8. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Parmar JR; Forrest BD; Freeman RA Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoids: Medical implications. Schrot RJ; Hubbard JR Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385 [TBL] [Abstract][Full Text] [Related]
10. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]. Basinski H; Jensen HB; Stenager E Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886 [TBL] [Abstract][Full Text] [Related]
12. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law. Mead A Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144 [TBL] [Abstract][Full Text] [Related]
13. Medical Marijuana programs: implications for cannabis control policy--observations from Canada. Fischer B; Kuganesan S; Room R Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942 [TBL] [Abstract][Full Text] [Related]
14. A Survey on the Medical Use of Cannabis in Europe: A Position Paper. Bramness JG; Dom G; Gual A; Mann K; Wurst FM Eur Addict Res; 2018; 24(4):201-205. PubMed ID: 30134238 [TBL] [Abstract][Full Text] [Related]
16. Is the clinical use of cannabis by oncology patients advisable? Bar-Sela G; Avisar A; Batash R; Schaffer M Curr Med Chem; 2014 Jun; 21(17):1923-30. PubMed ID: 24606496 [TBL] [Abstract][Full Text] [Related]
17. Cannabis for Pain and Headaches: Primer. Kim PS; Fishman MA Curr Pain Headache Rep; 2017 Apr; 21(4):19. PubMed ID: 28281107 [TBL] [Abstract][Full Text] [Related]
18. Cannabis and cannabinoids in cancer pain management. Meng H; Dai T; Hanlon JG; Downar J; Alibhai SMH; Clarke H Curr Opin Support Palliat Care; 2020 Jun; 14(2):87-93. PubMed ID: 32332209 [TBL] [Abstract][Full Text] [Related]
19. Why Insurance Companies Should Pay for Medical Cannabis. Casarett D; Abrams DI Am J Bioeth; 2019 Apr; 19(4):8-10. PubMed ID: 30994419 [No Abstract] [Full Text] [Related]
20. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. Hill KP JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]